|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:activities
|
progestin activity
|
|
gptkbp:affects
|
gptkb:ovulation
gptkb:menstrual_cycle
endometrial lining
|
|
gptkbp:appointed_by
|
oral tablet
|
|
gptkbp:approves
|
gptkb:1964
|
|
gptkbp:brand
|
Aygestin
Micronor
Nor-QD
|
|
gptkbp:class
|
gptkb:physicist
|
|
gptkbp:clinical_trial
|
gptkb:skincare_product
Phase IV
infertility treatment
menstrual disorders
amenorrhea
dysmenorrhea
|
|
gptkbp:contraindication
|
liver disease
pregnancy
history of thromboembolic disorders
|
|
gptkbp:developed_by
|
gptkb:Organon
|
|
gptkbp:dissolved
|
lipophilic
|
|
gptkbp:formulation
|
combination with estrogen
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
norethindrone acetate
|
|
gptkbp:ingredients
|
C20 H24 N2 O3
|
|
gptkbp:interacts_with
|
gptkb:St._John's_Wort
antibiotics
anticonvulsants
|
|
gptkbp:is_atype_of
|
G03 A C03
|
|
gptkbp:is_available_on
|
generic medication
|
|
gptkbp:is_used_for
|
hormone replacement therapy
contraception
treatment of endometriosis
|
|
gptkbp:lifespan
|
8-12 hours
|
|
gptkbp:manager
|
oral
|
|
gptkbp:marketed_as
|
gptkb:Australia
gptkb:United_Kingdom
gptkb:United_States
gptkb:Native_American_tribe
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:produced_by
|
19-nortestosterone
|
|
gptkbp:products
|
gptkb:levonorgestrel
etonogestrel
desogestrel
medroxyprogesterone acetate
|
|
gptkbp:safety_features
|
Category X
|
|
gptkbp:side_effect
|
headache
nausea
weight gain
breast tenderness
mood changes
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:type_of
|
51-98-9
|
|
gptkbp:bfsParent
|
gptkb:Loestrin
gptkb:Loestrin_24_Fe
gptkb:Necon_10/11
|
|
gptkbp:bfsLayer
|
6
|